Literature DB >> 24797326

Functional distinction between NGF-mediated plasticity and regeneration of nociceptive axons within the spinal cord.

C-L Lin1, P Heron2, S R Hamann3, G M Smith4.   

Abstract

Successful regeneration after injury requires either the direct reformation of the circuit or the formation of a bridge circuit to provide partial functional return through a more indirect route. Presently, little is known about the specificity of how regenerating axons reconnect or reconstruct functional circuits. We have established an in vivo Dorsal root entry zone (DREZ) model, which in the presence of Nerve Growth Factor (NGF), shows very robust regeneration of peptidergic nociceptive axons, but not other sensory axons. Expression of NGF in normal, non-injured animals leads to robust sprouting of only the peptidergic nociceptive axons. Interestingly, NGF-induced sprouting of these axons leads to severe chronic pain, whereas, regeneration leads to protective-like pain without chronic pain. Using this model we set out to compare differences in behavioral outcomes and circuit features between these two groups. In this study, we examined pre-synaptic and post-synaptic markers to evaluate the relationship between synaptic connections and behavioral responses. NGF-induced sprouting of calcitonin gene-related peptide (CGRP) axons resulted in a significant redistribution of synapses and cFos expression into the deeper dorsal horn. Regeneration of only the CGRP axons showed a general reduction in synapses and cFos expression within laminae I and II; however, inflammation of the hindpaw induced peripheral sensitization. These data show that although NGF-induced sprouting of peptidergic axons induces robust chronic pain and cFos expression throughout the entire dorsal horn, regeneration of the same axons resulted in normal protective pain with a synaptic and cFos distribution similar, albeit significantly less than that shown by the sprouting of CGRP axons.
Copyright © 2014 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  hyperalgesia; nerve growth factor; nociceptor; plasticity; regeneration

Mesh:

Substances:

Year:  2014        PMID: 24797326      PMCID: PMC4103020          DOI: 10.1016/j.neuroscience.2014.04.053

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  51 in total

1.  Intrathecally injected neurotrophins and the release of substance P from the rat isolated spinal cord.

Authors:  M Malcangio; M S Ramer; T J Boucher; S B McMahon
Journal:  Eur J Neurosci       Date:  2000-01       Impact factor: 3.386

2.  Functional regeneration of sensory axons into the adult spinal cord.

Authors:  M S Ramer; J V Priestley; S B McMahon
Journal:  Nature       Date:  2000-01-20       Impact factor: 49.962

3.  The modality-specific contribution of peptidergic and non-peptidergic nociceptors is manifest at the level of dorsal horn nociresponsive neurons.

Authors:  Jie Zhang; Daniel J Cavanaugh; Michael I Nemenov; Allan I Basbaum
Journal:  J Physiol       Date:  2012-12-24       Impact factor: 5.182

4.  Nerve growth factor in glia and inflammatory cells of the injured rat spinal cord.

Authors:  N R Krenz; L C Weaver
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

5.  Differential expression of synaptoporin and synaptophysin in primary sensory neurons and up-regulation of synaptoporin after peripheral nerve injury.

Authors:  T Sun; H-S Xiao; P-B Zhou; Y-J Lu; L Bao; X Zhang
Journal:  Neuroscience       Date:  2006-06-13       Impact factor: 3.590

6.  Efficient analysis of experimental observations.

Authors:  W J Dixon
Journal:  Annu Rev Pharmacol Toxicol       Date:  1980       Impact factor: 13.820

Review 7.  Neuronal plasticity: increasing the gain in pain.

Authors:  C J Woolf; M W Salter
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

8.  NGF message and protein distribution in the injured rat spinal cord.

Authors:  Arthur Brown; Mary-Jo Ricci; Lynne C Weaver
Journal:  Exp Neurol       Date:  2004-07       Impact factor: 5.330

9.  Semaphorin3A inhibits nerve growth factor-induced sprouting of nociceptive afferents in adult rat spinal cord.

Authors:  Xiao-Qing Tang; Darrell L Tanelian; George M Smith
Journal:  J Neurosci       Date:  2004-01-28       Impact factor: 6.167

10.  Netrin participates in the development of retinotectal synaptic connectivity by modulating axon arborization and synapse formation in the developing brain.

Authors:  Colleen Manitt; Angeliki M Nikolakopoulou; David R Almario; Sarah A Nguyen; Susana Cohen-Cory
Journal:  J Neurosci       Date:  2009-09-09       Impact factor: 6.167

View more
  11 in total

1.  Fabrication and characterization of microspheres encapsulating astrocytes for neural regeneration.

Authors:  Marcus Berndt; Yongchao Li; Negar Seyedhassantehrani; Li Yao
Journal:  ACS Biomater Sci Eng       Date:  2016-07-05

2.  Neurotrophin selectivity in organizing topographic regeneration of nociceptive afferents.

Authors:  Lakshmi Kelamangalath; Xiaoqing Tang; Kathleen Bezik; Noelle Sterling; Young-Jin Son; George M Smith
Journal:  Exp Neurol       Date:  2015-06-06       Impact factor: 5.330

3.  Nerve Growth Factor Gene Therapy: Activation of Neuronal Responses in Alzheimer Disease.

Authors:  Mark H Tuszynski; Jennifer H Yang; David Barba; Hoi-Sang U; Roy A E Bakay; Mary M Pay; Eliezer Masliah; James M Conner; Peter Kobalka; Subhojit Roy; Alan H Nagahara
Journal:  JAMA Neurol       Date:  2015-10       Impact factor: 18.302

4.  Postinjury Induction of Activated ErbB2 Selectively Hyperactivates Denervated Schwann Cells and Promotes Robust Dorsal Root Axon Regeneration.

Authors:  Seung Baek Han; Hyukmin Kim; Hyunkyoung Lee; Matthew Grove; George M Smith; Young-Jin Son
Journal:  J Neurosci       Date:  2017-10-05       Impact factor: 6.167

5.  Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated stem cell release in a mouse model of type 1 diabetes with limb ischaemia.

Authors:  Zexu Dang; Elisa Avolio; Ambra Albertario; Graciela B Sala-Newby; Anita C Thomas; Nianhong Wang; Costanza Emanueli; Paolo Madeddu
Journal:  Diabetologia       Date:  2019-04-24       Impact factor: 10.122

Review 6.  Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety.

Authors:  Martin Schmelz; Patrick Mantyh; Anne-Marie Malfait; John Farrar; Tony Yaksh; Leslie Tive; Lars Viktrup
Journal:  Pain       Date:  2019-10       Impact factor: 7.926

Review 7.  Mechanisms of Stem Cell Therapy in Spinal Cord Injuries.

Authors:  Munehisa Shinozaki; Narihito Nagoshi; Masaya Nakamura; Hideyuki Okano
Journal:  Cells       Date:  2021-10-06       Impact factor: 6.600

8.  Human Embryonic Stem Cell-Derived Progenitors Assist Functional Sensory Axon Regeneration after Dorsal Root Avulsion Injury.

Authors:  Jan Hoeber; Carl Trolle; Niclas Konig; Zhongwei Du; Alessandro Gallo; Emmanuel Hermans; Hakan Aldskogius; Peter Shortland; Su-Chun Zhang; Ronald Deumens; Elena N Kozlova
Journal:  Sci Rep       Date:  2015-06-08       Impact factor: 4.996

Review 9.  Nerve Growth Factor Signaling and Its Contribution to Pain.

Authors:  Philip A Barker; Patrick Mantyh; Lars Arendt-Nielsen; Lars Viktrup; Leslie Tive
Journal:  J Pain Res       Date:  2020-05-26       Impact factor: 3.133

10.  The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-Analysis.

Authors:  Si Yang; Yu Huang; Ziqi Ye; Lu Li; Yu Zhang
Journal:  Front Pharmacol       Date:  2020-06-30       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.